Qian Gao

Qian Gao

Vanitha Margan

Vanitha Margan

Brett Houser

Brett Houser

Presented by:

Qian Gao, PhD, R&D Manager, Bio‑Plex Immunoassays, Bio-Rad Laboratories, Inc.

Vanitha Margan, Global Product Manager, Bio-Plex Immunoassays, Bio-Rad

Brett Houser, Global Product Manager, Bio-Plex Immunoassays, Bio-Rad

Available on Demand


In this webinar, we discuss the utilization of the Bio-Plex Pro Human SARS-CoV-2 Neutralization Antibody Custom Assay Developer Kit to efficiently develop new assays for the detection and determination of percentage inhibition of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibodies with affinity to SARS-CoV-2 variants. Using the Bio-Plex Pro Kit, a neutralizing antibody assay can be developed in just one day, as compared to the multiple days required for traditional assays.

Watch Webinar
Previous post

Purification of DNA Oligonucleotides using Anion Exchange Chromatography

Next post

Quick Tips for Bio-Plex Assays